Webinar: Supplement cGMP Basics for Hemp-CBD Companies

AHPA Alerts

AHPA keeps members and the industry informed of recent news and developments that impact the trade through email alerts. Subscribe to news as it happens or a weekly summary of all alerts.

Subscribe >>

View recent alerts:

Subscribe to AHPA Updates to stay informed about the latest AHPA news and resources.

Recent News

Webinar: Supplement cGMP Basics for Hemp-CBD Companies

Hemp-CBD supplement companies should be cognizant of federal manufacturing requirements

Published: Tuesday, November 5, 2019

Event date: 12/10/2019 1:00 PM - 3:00 PM Export event


Event Details

Date: Dec. 10, 2019

Time: 1-3pm EDT


  • AHPA and HIA Members - $199
    • $298 for both Dec. webinars
  • Non-Members - $399
    • $698 for both Dec. webinars

Attend this webinar for an overview of dietary supplement current good manufacturing (cGMP) requirements for hemp-CBD products. Legal and industry experts will provide strategies and resources to comply and document compliance with these federal manufacturing requirements designed to ensure product quality and safety.

AHPA recommends that any manufacturer, labeler, packer, holder or marketer of dietary supplements that contain hemp or CBD comply with all applicable federal regulations, including current good manufacturing practice (cGMP) requirements. The dietary supplement cGMP rule requires those who manufacture, package, label, or hold a dietary supplement to establish and follow current good manufacturing practice to ensure the quality of the dietary supplement and to ensure that the dietary supplement is packaged and labeled as specified in the master manufacturing record. Compliance with dietary supplement cGMP regulations helps ensure product quality and safety.

If you’re in the hemp-CBD supplement marketplace, you need to understand how cGMP requirements apply to your business model.


  • Overview of cGMP requirements
  • Strategies to comply and document compliance
  • cGMP resources for hemp-CBD companies
  • Preparing for and conducting an FDA cGMP inspection

Answers to your questions

A 20-30-minute Q&A session will follow the speaker presentations to answer attendees' specific questions. Submit your questions before the live event via email to Natasha Weaver.


  • Tara Lin Couch, Ph.D., 
  • A. Wes Siegner, Esq., Senior Counsel, Hyman, Phelps & McNamara PC
  • Asa Waldstein, Vice President of Operations & Regulatory Affairs, Advanced Extraction


  • Presenter slides
  • Presenter biographies
  • Hemp-CBD legal status report

More links

2019 Annual Fund Sponsors


AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.